Important advice for fertile women:
Topamax may cause harm to a baby during pregnancy. If you are a fertile woman, consult your doctor about other possible treatments. Visit your doctor to review your treatment and discuss the risks at least once a year.
Prevention of migraines
Treatment of epilepsy
Risks of topiramate when taken during pregnancy (regardless of the condition for which topiramate is used) are as follows:
There is a risk of harm to the baby during pregnancy if Topamax is used during pregnancy.
Need for contraceptive methods for fertile women:
Use of Topamax in girls:
If you are the parent/caregiver of a girl treated with Topamax,you should consult your doctor immediately once your daughter experiences her first menstrual period (menarche). The doctor will inform you about the risks to a baby during pregnancy due to exposure to topiramate during pregnancy, and about the need to use highly effective contraceptive methods.
If you want to become pregnant while taking Topamax:
If you have become pregnant or think you may be pregnant while taking Topamax:
Make sure to read the patient guide that your doctor will provide you withor scan the QR code to obtain it (see section6 “Other sources of information”). A patient card is provided with the Topamax packaging to remind you of the risks during pregnancy.
Breastfeeding
The active ingredient of Topamax(topiramate) passes into breast milk. Adverse effects have been observed in breastfed infants of mothers treated with Topamax, including diarrhea, feeling sleepy, feeling irritable, and low weight gain. Therefore, your doctor will discuss with you whether to interrupt breastfeeding or whether to interrupt the treatment with Topamax. Your doctor will take into account the importance of the benefits for the mother and the risk to the baby.Mothers in the lactation period who are takingTopamaxshould inform their doctor as soon as possible if the baby experiences anything unusual.
Driving and operating machines
You may experience dizziness, fatigue, and visual disturbances during treatment withTopamax. Do not drive or operate tools or machineswithout speaking to your doctor.
Topamax contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Other excipients
This medication contains less than 1mmol of sodium (23mg) per tablet; this is, essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
Girls and fertile women:
Topamax treatment should begin and continue under the supervision of a doctor experienced in treating epilepsy or migraine. Visit your doctor to review your treatment at least once a year.
If you take more Topamax than you should:
You may experience an overdose if you are taking another medication with Topamax.
In case of overdose or accidental ingestion, you can also contact the Toxicological Information Service, Phone 91 5620420.
If you forgot to take Topamax
If you interrupt the treatment with Topamax
Do not stop treatment without your doctor's instructions. Your symptoms may return. If your doctor decides that you should stop taking this medication, they will gradually reduce your dose over several days.
If you have any other questions about the use of this product, ask your doctor or pharmacist.
Like all medications,this medicationmay cause side effects, although not everyone will experience them.
Consult your doctor or seek medical attention immediately if you experience any of the following side effects:
Very common (may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Unknown (cannot be estimated from available data):
Other side effects include the following, if severe, please consult your doctor or pharmacist:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Unknown (cannot be estimated from available data)
Other side effects in children
Generally, side effects observed in children are similar to those observed in adults, but the following side effects may be more common in children than in adults:
Other side effects that may occur in children are:
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es.By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not usethis medicationafter the expiration date that appears on the blister/packaging/container after CAD. The expiration date is the last day of the month indicated.
Do not store at a temperature above25ºC.
Blister packs: Store in the original packaging to protect the tablets from moisture.
Bottles: Store in the original packaging and keep the bottle perfectly closed to protect the tablets from moisture.
Medicines should not be disposed of through drains or in the trash.Deposit the containers and medicines that you no longer need at theSIGREpharmacy drop-off point. If in doubtask your pharmacist how to dispose of the containers and medicines that you no longer need. By doing so, you will help protect the environment.
Composition of Topamax
1 OPADRY contains: hypromellose, macrogol, polisorbate 80, and as a colorant, titanium dioxide E171 and iron oxide red E172.
200 mg: salmon-colored, rounded tablets, 10 mm in diameter, with the inscription "TOP" on one face and "200" on the other face.
Transparent plastic bottle with a tamper-evident closure containing 20, 28, 30, 50, 56, 60, 100, or 200 (2x100) tablets. Each bottle includes a desiccant that should not be ingested.
Aluminum/aluminum blister pack. Package sizes: 10, 20, 28, 30, 50, 56, 60, 100, or 200 (2x100) tablets. Each blister pack (alu/alu) is contained within a protective bag.
Only some package sizes may be marketed.
JANSSEN-PHARMA, S.L.
Pº de las Doce Estrellas, 5-7
28042 Madrid
Spain
Manufacturer responsible
Janssen Pharmaceutica NV
Turnhoutseweg 30,
Belgium
or
Janssen-Cilag SpA
Via C. Janssen,
Borgo San Michele
04100
Latina
Italy
or
Lusomedicamenta – Sociedade Técnica Farmacêutica S.A.
Estrada Consiglieri Pedroso nº 69 B
Queluz de Baixo
2730-055 Barcarena
Portugal
This medicine is authorized in the member states of the European Economic Area with the following names:
Austria, Belgium, Cyprus, Czech Republic, Estonia, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain: | Topamax |
Denmark, Finland, Iceland, Norway, Sweden: | Topimax |
France: | Epitomax |
Greece: | Topamac |
Last review date of this leaflet:March 2024.
Other sources of information
The most recent approved patient guide information for this medicine is available by scanning the following QR code with a smartphone. The same information is also available on the following website (URL):
https://cima.aemps.es/cima/DocsPub/16/3252
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.